CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 26 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $41,000 | -88.4% | 58,158 | -50.0% | 0.01% | -84.8% |
| Q3 2014 | $354,000 | -0.8% | 116,316 | 0.0% | 0.03% | +17.9% |
| Q2 2014 | $357,000 | -16.6% | 116,316 | 0.0% | 0.03% | -3.4% |
| Q1 2014 | $428,000 | -8.5% | 116,316 | 0.0% | 0.03% | -6.5% |
| Q4 2013 | $468,000 | -5.6% | 116,316 | 0.0% | 0.03% | -41.5% |
| Q3 2013 | $496,000 | +44.6% | 116,316 | 0.0% | 0.05% | +51.4% |
| Q2 2013 | $343,000 | – | 116,316 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 250,000 | $920,000 | 0.42% |
| Rotella Capital Management, Inc. | 19,639 | $72,000 | 0.09% |
| Invesco Private Capital | 116,316 | $428,000 | 0.03% |
| SHUFRO ROSE & CO LLC | 26,500 | $97,000 | 0.01% |
| Allianz Asset Management GmbH | 559,207 | $2,058,000 | 0.00% |
| North Star Investment Management Corp. | 1,857 | $7,000 | 0.00% |
| UBS AG | 1,000 | $4,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 4,300 | $16,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 26,712 | $98,000 | 0.00% |
| NORTHERN TRUST CORP | 32,991 | $121,000 | 0.00% |